A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Design, 2-Arm Study to Investigate the Efect of Aprotinin on Transfusion Requirements in Patients Undergoing Surgical Procedures for Lung or Esophogus Cancer

Grants and Contracts Details

StatusFinished
Effective start/end date4/12/06 → 3/31/07

Funding

  • Bayer Pharmaceuticals: $2,500.00